Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Histone deacetylase inhibitor tributyrin and vitamin A in cancer (2017)

  • Authors:
  • USP affiliated authors: HEIDOR, RENATO - FCF ; MORENO, FERNANDO SALVADOR - FCF
  • USP Schools: FCF; FCF
  • DOI: 10.1007/978-3-319-31143-2_72-1
  • Subjects: VITAMINA A; METILAÇÃO DE DNA
  • Language: Inglês
  • Imprenta:
  • ISBN: 978-33-19311-43-2
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1007/978-3-319-31143-2_72-1 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      HEIDOR, Renato; VARGAS-MENDEZ, Ernesto; MORENO, Fernando Salvador. Histone deacetylase inhibitor tributyrin and vitamin A in cancer. In: Handbook of Nutrition, Diet, and Epigenetics[S.l: s.n.], 2017. DOI: 10.1007/978-3-319-31143-2_72-1.
    • APA

      Heidor, R., Vargas-Mendez, E., & Moreno, F. S. (2017). Histone deacetylase inhibitor tributyrin and vitamin A in cancer. In Handbook of Nutrition, Diet, and Epigenetics. Cham: Springer. doi:10.1007/978-3-319-31143-2_72-1
    • NLM

      Heidor R, Vargas-Mendez E, Moreno FS. Histone deacetylase inhibitor tributyrin and vitamin A in cancer. In: Handbook of Nutrition, Diet, and Epigenetics. Cham: Springer; 2017.
    • Vancouver

      Heidor R, Vargas-Mendez E, Moreno FS. Histone deacetylase inhibitor tributyrin and vitamin A in cancer. In: Handbook of Nutrition, Diet, and Epigenetics. Cham: Springer; 2017.

    Referências citadas na obra
    Ahmad A, Sakr WA, Rahman KM (2012) Novel targets for detection of cancer and their modulation by chemopreventive natural compounds. Front Biosci (Ellite Ed) 4:410–425
    Al Tanoury Z, Piskunov A, Rochette-Egly C (2013) Vitamin a and retinoid signaling: genomic and nongenomic effects. J Lipid Res 54:1761–1775
    Alcantara EN, Speckmann EW (1976) Diet, nutrition, and cancer. Am J Clin Nutr 29:1035–1047
    Alizadeh F, Bolhassani A, Khavari A et al (2014) Retinoids and their biological effects against cancer. Int Immunopharmacol 18:43–49
    Andrade FO, Nagamine MK, Conti AD et al (2012) Efficacy of the dietary histone deacetylase inhibitor butyrate alone or in combination with vitamin a against proliferation of MCF-7 human breast cancer cells. Braz J Med Biol Res 45:841–850
    Banudevi S, Swaminathan S, Maheswari KU (2015) Pleiotropic role of dietary phytochemicals in cancer: emerging perspectives for combinational therapy. Nutr Cancer 67:1021–1048
    Berni Canani R, Di Costanzo M, Leone L (2012) The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 4:4
    Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866
    Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940–954
    Chen ZX, Breitman TR (1994) Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res 54:3494–3499
    Chen Z, Wang W, Pan J et al (1999) Combination of all-trans retinoic acid with butyric acid and its prodrugs markedly enhancing differentiation of human acute promyelocytic leukemia NB4 cells. Chin Med J 112:352–355
    Cheong HS, Lee HC, Park BL et al (2010) Epigenetic modification of retinoic acid-treated human embryonic stem cells. BMB Rep 43:830–835
    Conley BA, Egorin MJ, Tait N et al (1998) Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin Cancer Res 4:629–634
    Cordani M, Butera G, Pacchiana R et al (2016) Molecular interplay between mutant p53 proteins and autophagy in cancer cells. Biochim Biophys Acta 1867:19–28
    Daniel P, Brazier M, Cerutti I et al (1989) Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts. Clin Chim Acta 181:255–263
    Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133:2485S–2493S
    de Conti A, Kuroiwa-Trzmielina J, Horst MA et al (2012) Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin a during the promotion phase of rat hepatocarcinogenesis. J Nutr Biochem 23:860–866
    de Conti A, Tryndyak V, Koturbash I et al (2013) The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway. Carcinogenesis 34:1900–1906
    di Masi A, Leboffe L, De Marinis E et al (2015) Retinoic acid receptors: from molecular mechanisms to cancer therapy. Mol Asp Med 41:1–115
    Donohoe DR, Bultman SJ (2012) Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol 227:3169–3177
    Donohoe DR, Collins LB, Wali A et al (2012) The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 48:612–626
    Edelman MJ, Bauer K, Khanwani S et al (2003) Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug. Cancer Chemother Pharmacol 51:439–444
    Egorin MJ, Yuan ZM, Sentz DL et al (1999) Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats. Cancer Chemother Pharmacol 43:445–453
    Esteller M, Guo M, Moreno V et al (2002) Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer. Cancer Res 62:5902–5905
    Farfán M, Villalón MJ, Ortíz ME et al (2013) The effect of interesterification on the bioavailability of fatty acids in structured lipids. Food Chem 139:571–577
    Fonseca EMAV, Chagas CE, Mazzantini RP et al (2005) All-trans and 9-cis retinoic acids, retinol and beta-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage. Carcinogenesis 26:1940–1946
    Gilardi F, Desvergne B (2014) RXRs: collegial partners. Subcell Biochem 70:75–102
    Gori GB (1978) Role of diet and nutrition in cancer cause, prevention and treatment. Bull Cancer 65:115–126
    Guariento AH, Furtado KS, de Conti A et al (2014) Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis. Int J Cancer 135:7–18
    Gudas LJ (2013) Retinoids induce stem cell differentiation via epigenetic changes. Semin Cell Dev Biol 24:701–705
    Hansen NJ, Wylie RC, Phipps SM et al (2007) The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells. Int J Oncol 30:641–650
    Hayden LJ, Satre MA (2002) Alterations in cellular retinol metabolism contribute to differential retinoid responsiveness in normal human mammary epithelial cells versus breast cancer cells. Breast Cancer Res Treat 72:95–105
    Heidor R, Ortega JF, de Conti A et al (2012) Anticarcinogenic actions of tributyrin, a butyric acid prodrug. Curr Drug Targets 13:1720–1729
    Heidor R, de Conti A, Ortega JF et al (2016) The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis. Mol Nutr Food Res 60:420–429
    Huang J, Plass C, Gerhauser C (2011) Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 12:1925–1956
    Humphreys KJ, Cobiac L, Le Leu RK et al (2013) Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Mol Carcinog 52:459–474
    Jia H, Zhang Z, Zou D et al (2014) MicroRNA-10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells. PLoS One 9:e88057
    Kang SN, Lee E, Lee MK et al (2011) Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma. Drug Deliv 18:143–149
    Khan S, Wall D, Curran C et al (2015) MicroRNA-10a is reduced in breast cancer and regulated in part through retinoic acid. BMC Cancer 15(1):345
    Kim KB, Nam YA, Kim HS et al (2014) α Linolenic acid: nutraceutical, − pharmacological and toxicological evaluation. Food Chem Toxicol 70:163–178
    Kitareewan S, Pitha-Rowe I, Sekula D et al (2002) UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia. Proc Natl Acad Sci USA 99:3806–3811
    Kotecha R, Takami A, Espinoza JL (2016) Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 7:52517–52529
    Kumar P, Periyasamy R, Das S et al (2014) All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modification. Mol Pharmacol 85:946–957
    Kuroiwa-Trzmielina J, de Conti A, Scolastici C et al (2009) Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. Int J Cancer 124:2520–2527
    Leder A, Leder P (1975) Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 5:319–322
    Li M, Sun Y, Guan X et al (2014) Advanced progress on the relationship between RA and its receptors and malignant tumors. Crit Rev Oncol Hematol 91:271–282
    Liu Y, Upadhyaya B, Fardin-Kia AR et al (2016) Dietary resistant starch type 4-derived butyrate attenuates nuclear factor-kappa-B1 through modulation of histone H3 trimethylation at lysine 27. Food Funct 7:3772–3781
    Lo-Coco F, Ammatuna E (2006) The biology of acute promyelocytic leukemia and its impact on diagnosis and treatment. Hematology Am Soc Hematol Educ Program 1:156–161
    Louis P, Flint HJ (2009) Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 294:1–8
    Makishima M, Honma Y (1997) Tretinoin tocoferil as a possible differentiation-inducing agent against myelomonocytic leukemia. Leuk Lymphoma 26:43–48
    Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841–850
    McCollum EV, Davis M (1913) The necessity of certain lipids during growth. J Biol Chem 15:167–175
    Michels KB (2005) The role of nutrition in cancer development and prevention. Int J Cancer 114:163–165
    Miller AA, Kurschel E, Osieka R et al (1987) Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur J Cancer Clin Oncol 23:1283–1287
    Mongan NP, Gudas LJ (2005) Valproic acid, in combination with all-trans retinoic acid and 5-aza-2′-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells. Mol Cancer Ther 4:477–486
    Moreno FS, S-Wu T, Naves MM et al (2002) Inhibitory effects of beta-carotene and vitamin a during the progression phase of hepatocarcinogenesis involve inhibition of cell proliferation but not alterations in DNA methylation. Nutr Cancer 44:80–88
    Ogawa K, Yasumura S, Atarashi Y et al (2004) Sodium butyrate enhances Fas-mediated apoptosis of human hepatoma cells. J Hepatology 40:278–284
    Ong TP, Moreno FS, Ross SA (2011) Targeting the epigenome with bioactive food components for cancer prevention. J Nutrigenet Nutrigenomics 4:275–292
    Ortega JF, de Conti A, Tryndyak V et al (2016) Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Oncotarget 7:24339–24347
    Pascale RM, Simile MM, Calvisi DF et al (2005) Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer. Hepatology 42:1310–1319
    Perng W, Rozek LS, Mora-Plazas M et al (2012) Micronutrient status and global DNA methylation in school-age children. Epigenetics 7:1133–1141
    Prasad KN, Sinha PK (1976) Effect of sodium butyrate on mammalian cells in culture: a review. In Vitro 12:125–132
    Qi L, Guo Y, Zhang P et al (2016) Preventive and therapeutic effects of the retinoid X receptor agonist bexarotene on tumors. Curr Drug Metab 17:118–128
    Raif A, Marshall GM, Bell JL et al (2009) The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylation. Cancer Lett 277:82–90
    Rajaram S (2014) Health benefits of plant-derived α-linolenic acid. Am J Clin Nutr 100(Suppl 1):443S–448S
    Rephaeli A, Nordenberg J, Aviram A et al (1994) Butyrate-induced differentiation in leukemic myeloid cells in vitro and in vivo studies. Int J Oncol 4:1387–1391
    Rowling MJ, McMullen MH, Schalinske KL (2002) Vitamin a and its derivatives induce hepatic glycine N-methyltransferase and hypomethylation of DNA in rats. J Nutr 132:365–369
    Savickiene J, Treigyte G, Borutinskaite VV et al (2012) Antileukemic activity of combined epigenetic agents, DNMT inhibitors zebularine and RG108 with HDAC inhibitors, against promyelocytic leukemia HL-60 cells. Cell Mol Biol Lett 17:501–525
    Schenk T, Stengel S, Zelent A (2014) Unlocking the potential of retinoic acid in anticancer therapy. Br J Cancer 111:2039–2045
    Schlörmann W, Naumann S, Renner C et al (2015) Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and cyclin D2 in human colon adenoma cells. Genes Nutr 10:50
    Silva EL, Carneiro G, Caetano PA et al (2015) Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid. Expert Rev Anticancer Ther 15:247–256
    Spurling CC, Suhl JA, Boucher N et al (2008) The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells. Nutr Cancer 60:692–702
    Steward WP, Brown K (2013) Cancer chemoprevention: a rapidly evolving field. Br J Cancer 109:1–7
    Stommel JM, Marchenko ND, Jimenez GS et al (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18:1660–1672
    Su J, He L, Zhang N et al (2006) Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: pharmacokinetics in adult male Wistar rats and cellular activity on Caco-2 and HepG2 cell lines. J Pharmacol Exp Ther 316:62–70
    Su J, Zhang N, Ho PC (2008) Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on Caco-2 and HepG2 cell lines. J Pharm Sci 97:2844–2853
    Taimi M, Chen ZX, Breitman TR (1998) Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide. Oncol Res 10:75–84
    Tang XH, Gudas LJ (2011) Retinoids, retinoic acid receptors, and cancer. Annu Rev Pathol 6:345–364
    Trasino SE, Tang XH, Jessurun J et al (2016) Retinoic acid receptor β2 agonists restore glycaemic control in diabetes and reduce steatosis. Diabetes Obes Metab 18:142–151
    Uray IP, Dmitrovsky E, Brown PH (2016) Retinoids and rexinoids in cancer prevention: from laboratory to clinic. Semin Oncol 43:49–64
    Urvalek A, Laursen KB, Gudas LJ (2014) The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes. Subcell Biochem 70:129–149
    Van der Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
    Veal G, Rowbotham S, Boddy A (2007) Pharmacokinetics and pharmacogenetics of 13-cis-retinoic acid in the treatment of neuroblastoma. Therapie 62:91–93
    Vinolo MA, Rodrigues HG, Festuccia WT et al (2012) Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice. Am J Physiol Endocrinol Metab 303:E272–E282
    Wang H (2014) Predicting cancer-related MiRNAs using expression profiles in tumor tissue. Curr Pharm Biotechnol 15:438–444
    Wang HG, Huang XD, Shen P et al (2013) Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro. Int J Mol Med 31:967–974
    Wei X, Peng R, Cao J et al (2016) Serum vitamin a status is associated with obesity and the metabolic syndrome among school-age children in Chongqing. China Asia Pac J Clin Nutr 25:563–570
    Witt O, Schmejkal S, Pekrun A (2000) Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells. Am J Hematol 64:319–321
    World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington, DC
    Xiao X, Sidorov IA, Gee J et al (2005) Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol 79:108–117
    Xie C, Wu B, Chen B et al (2016) Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2-p53 signaling. Onco Targets Ther 9:4005–4013
    Zhang M, Guo R, Xu H et al (2011) Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma. Nucl Med Commun 32:605–610
    Zhang J, Gao Y, Yu M et al (2015) Retinoic acid induces embryonic stem cell differentiation by altering both encoding RNA and microRNA expression. PLoS One 10:e0132566